Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Dan Chen, Teng Chen, Lihong Wang, Zhihua Zhang & Enhong Xing. (2022) Circulating miR-448 acts as a potential diagnostic biomarker for multiple myeloma. Hematology 27:1, pages 847-852.
Read now
Read now
Cong Xu & Yunfeng Fu. (2021) Expression Profiles of tRNA-Derived Fragments and Their Potential Roles in Multiple Myeloma. OncoTargets and Therapy 14, pages 2805-2814.
Read now
Read now
Dorival Mendes Rodrigues-Junior, Maria Fernanda de Andrade Pelarin, Helena Bonciani Nader, André Luiz Vettore & Maria Aparecida Silva Pinhal. (2021) MicroRNA-1252-5p Associated with Extracellular Vesicles Enhances Bortezomib Sensitivity in Multiple Myeloma Cells by Targeting Heparanase. OncoTargets and Therapy 14, pages 455-467.
Read now
Read now
Zhen Huang, Guofeng Su, Xiaoxia Bi, Libo Zhang, Zhuohui Xu & Ge Wang. (2021) Over-expression of long non-coding RNA insulin-like growth factor 2-antisense suppressed hepatocellular carcinoma cell proliferation and metastasis by regulating the microRNA-520h/cyclin-dependent kinase inhibitor 1A signaling pathway. Bioengineered 12:1, pages 6952-6966.
Read now
Read now
Ming-dian Lu, Dong Liu & Yong-xiang Li. (2020) RETRACTED ARTICLE: LINC01436 Promotes the Progression of Gastric Cancer via Regulating miR-513a-5p/APE1 Axis. OncoTargets and Therapy 13, pages 10607-10619.
Read now
Read now
Xue Zhou, Xiancheng Ma, Hang Sun, Xue Li, Huizhen Cao, Youzhang Jiang, Pingyu Wang, Shuyang Xie, Youjie Li & Yunxiao Sun. (2020) Let-7b regulates the adriamycin resistance of chronic myelogenous leukemia by targeting AURKB in K562/ADM cells . Leukemia & Lymphoma 61:14, pages 3451-3459.
Read now
Read now
Meijun Guo, Beibei Lin, Guoping Li, Jun Lin & Xiuxiu Jiang. (2020) LncRNA TDRG1 promotes the proliferation, migration, and invasion of cervical cancer cells by sponging miR-214-5p to target SOX4. Journal of Receptors and Signal Transduction 40:3, pages 281-293.
Read now
Read now
Articles from other publishers (25)
Rui Bergantim, Joana Jorge, Sara Peixoto da Silva, Raquel Alves, Ana Cristina Gonçalves, Ana Bela Sarmento-Ribeiro, José E. Guimarães & M. Helena Vasconcelos. 2024. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
Piotr Kulig, Karolina Łuczkowska, Estera Bakinowska, Bartłomiej Baumert & Bogusław Machaliński. (2023) Epigenetic Alterations as Vital Aspects of Bortezomib Molecular Action. Cancers 16:1, pages 84.
Crossref
Crossref
Richu Qu & Jinyu Ma. (2023) Circ_0091537 promotes gefitinib chemoresistance in non-small cell lung cancer by mediating the miR-520h/YAP1 network. Anti-Cancer Drugs 34:10, pages 1151-1161.
Crossref
Crossref
Mehrdad Hashemi, Sophie Mousavian Roshanzamir, Mahshid Deldar Abad Paskeh, Seyedeh Sara Karimian, Mahdiyeh Sadat Mahdavi, Simin Khorsand Kheirabad, Sahar Naeemi, Afshin Taheriazam, Shokooh Salimimoghaddam, Maliheh Entezari, Sepideh Mirzaei & Saeed Samarghandian. (2023) Non-coding RNAs and exosomal ncRNAs in multiple myeloma: An emphasis on molecular pathways. European Journal of Pharmacology 941, pages 175380.
Crossref
Crossref
Sara Peixoto da Silva, Hugo R. Caires, Rui Bergantim, José E. Guimarães & M. Helena Vasconcelos. (2022) miRNAs mediated drug resistance in hematological malignancies. Seminars in Cancer Biology 83, pages 283-302.
Crossref
Crossref
Chun‐Han Tang, Ling Qin, Ying‐Chun Gao, Tai‐Yu Chen, Ke Xu, Tao Liu & Tao Ren. (2022) APE1 shRNA‐loaded cancer stem cell‐derived extracellular vesicles reverse Erlotinib resistance in non‐small cell lung cancer via the IL‐6/STAT3 signalling. Clinical and Translational Medicine 12:5.
Crossref
Crossref
Ying Liu, Peng Cheng, Weihua Zhao, Lihua Zhu, Jingzhe Sui, Yi Dai & Yongrong Lai. (2022) MiR-197-3p reduces bortezomib resistance in multiple myeloma by inhibiting IL-6 expression in a MEAF6-dependent manner. Leukemia Research 114, pages 106785.
Crossref
Crossref
Linfei Hu, Jun Zhang, Mengran Tian, Ning Kang, Guangwei Xu, Jingtai Zhi, Xianhui Ruan, Xiukun Hou, Wei Zhang, Jiaoyu Yi, Weike Ma, Luchen Chang, Tao Tang, Xiangqian Zheng, Xi Wei & Ming Gao. (2022) Pharmacological inhibition of Ref-1 enhances the therapeutic sensitivity of papillary thyroid carcinoma to vemurafenib. Cell Death & Disease 13:2.
Crossref
Crossref
Giuseppe Valacchi, Erika Pambianchi, Simona Coco, Alessandra Pulliero & Alberto Izzotti. (2022) MicroRNA Alterations Induced in Human Skin by Diesel Fumes, Ozone, and UV Radiation. Journal of Personalized Medicine 12:2, pages 176.
Crossref
Crossref
Wenfeng He, Yonghui Fu, Yongliang Zheng, Xiaoping Wang, Bin Liu & Junquan Zeng. (2021) Diallyl thiosulfinate enhanced the anti-cancer activity of dexamethasone in the side population cells of multiple myeloma by promoting miR-127-3p and deactivating the PI3K/AKT signaling pathway. BMC Cancer 21:1.
Crossref
Crossref
Cong Xu, Ting Liang, Fangrong Zhang, Jing Liu & Yunfeng Fu. (2021) tRNA-derived fragments as novel potential biomarkers for relapsed/refractory multiple myeloma. BMC Bioinformatics 22:1.
Crossref
Crossref
Fu‐Ji Lai, Hua Yu, Yang‐Yang Xie & Ning He. (2021)
Circ_0000317/
microRNA
‐520g/
HOXD10
axis affects the biological characteristics of colorectal cancer
. The Kaohsiung Journal of Medical Sciences 37:11, pages 951-963.
Crossref
Crossref
Xiaolan Lai, Chuanqian Huang, Xuekun Nie, Qi Chen, Yirong Tang, Xianguo Fu, Ying Lin, Chengjun Nie, Xinyu Xu, Xiukang Wang, Renli Chen & Zichun Chen. (2021) Bortezomib Inhibits Multiple Myeloma Cells by Transactivating ATF3 to Trigger miR-135a-5p- Dependent Apoptosis. Frontiers in Oncology 11.
Crossref
Crossref
Jian-Ming Lü, Zhengdong Liang, Dongliang Liu, Bin Zhan, Qizhi Yao & Changyi Chen. (2021) Two Antibody-Guided Lactic-co-Glycolic Acid-Polyethylenimine (LGA-PEI) Nanoparticle Delivery Systems for Therapeutic Nucleic Acids. Pharmaceuticals 14:9, pages 841.
Crossref
Crossref
Peng Li, Hongsheng Wang, Ying Tang, Shuo Sun, Yue Ma, Yansong Xu & Guangyu Chen. (2021) Knockdown of LINC00657 inhibits the viability, migration and invasion of pancreatic cancer cells by regulating the miR‑520h/CKS1B axis. Experimental and Therapeutic Medicine 22:4.
Crossref
Crossref
Elisa Taiana, Maria Eugenia Gallo Cantafio, Vanessa Katia Favasuli, Cecilia Bandini, Giuseppe Viglietto, Roberto Piva, Antonino Neri & Nicola Amodio. (2021) Genomic Instability in Multiple Myeloma: A “Non-Coding RNA” Perspective. Cancers 13:9, pages 2127.
Crossref
Crossref
Haifei Chen, Weiling Cao, Jiao Chen, Danbo Liu, Lingyun Zhou, Fang Du & Feiqi Zhu. (2021) miR‐218 contributes to drug resistance in multiple myeloma via targeting LRRC28. Journal of Cellular Biochemistry 122:3-4, pages 305-314.
Crossref
Crossref
Alessandro Allegra, Roberta Ettari, Vanessa Innao & Alessandra Bitto. (2021) Potential Role of microRNAs in inducing Drug Resistance in Patients with Multiple Myeloma. Cells 10:2, pages 448.
Crossref
Crossref
Milad Ashrafizadeh, Ali Zarrabi, Sima Orouei, Kiavash Hushmandi, Azadeh Hakimi, Amirhossein Zabolian, Salman Daneshi, Saeed Samarghandian, Behzad Baradaran & Masoud Najafi. (2021) MicroRNA-mediated autophagy regulation in cancer therapy: The role in chemoresistance/chemosensitivity. European Journal of Pharmacology 892, pages 173660.
Crossref
Crossref
Amro M. Soliman, Teoh Seong Lin, Pasuk Mahakkanukrauh & Srijit Das. (2020) Role of microRNAs in Diagnosis, Prognosis and Management of Multiple Myeloma. International Journal of Molecular Sciences 21:20, pages 7539.
Crossref
Crossref
Wenwen Geng, Haiyun Song, Qianqian Zhao, Ke Dong, Qian Pu, Haidong Gao & Yanrong Lv. (2020) miR-520h Stimulates Drug Resistance to Paclitaxel by Targeting the OTUD3-PTEN Axis in Breast Cancer. BioMed Research International 2020, pages 1-11.
Crossref
Crossref
Wan-Li Ge, Qun Chen, Ling-Dong Meng, Xu-Min Huang, Guo-dong Shi, Qing-Qing Zong, Peng Shen, Yi-Chao Lu, Yi-Han Zhang, Yi Miao, Jing-Jing Zhang & Kui-Rong Jiang. (2020) The YY1/miR-548t-5p/CXCL11 signaling axis regulates cell proliferation and metastasis in human pancreatic cancer. Cell Death & Disease 11:4.
Crossref
Crossref
琳琳 刘. (2020) Research Progress of miRNA in Multiple Myeloma. World Journal of Cancer Research 10:01, pages 10-15.
Crossref
Crossref
Hyun Ah Seo, Sokviseth Moeng, Seokmin Sim, Hyo Jeong Kuh, Soo Young Choi & Jong Kook Park. (2019) MicroRNA-Based Combinatorial Cancer Therapy: Effects of MicroRNAs on the Efficacy of Anti-Cancer Therapies. Cells 9:1, pages 29.
Crossref
Crossref
Hiroshi Handa, Yuki Murakami, Rei Ishihara, Kei Kimura-Masuda & Yuta Masuda. (2019) The Role and Function of microRNA in the Pathogenesis of Multiple Myeloma. Cancers 11:11, pages 1738.
Crossref
Crossref